Skip to content
  • CONTACT US
  • CAREERS
  • Share
Allogene Logo
  • PIPELINE
    • AlloCAR T PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY
  • PIPELINE
    • AlloCAR T PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY

The Citizens JMP Hematology and Oncology Summit

  • Post author:Allogene Therapeutics
  • Post published:December 2, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingThe Citizens JMP Hematology and Oncology Summit

December 2, 2024 11:00 AM EST : The Citizens JMP Hematology and Oncology Summit

  • Post author:Allogene Therapeutics Events
  • Post published:December 2, 2024
  • Post category:Uncategorized

Continue ReadingDecember 2, 2024 11:00 AM EST : The Citizens JMP Hematology and Oncology Summit

November 20, 2024 6:30 AM EST : Jefferies London Healthcare Conference

  • Post author:Allogene Therapeutics Events
  • Post published:November 20, 2024
  • Post category:Uncategorized

Continue ReadingNovember 20, 2024 6:30 AM EST : Jefferies London Healthcare Conference

Jefferies London Healthcare Conference

  • Post author:Allogene Therapeutics
  • Post published:November 20, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingJefferies London Healthcare Conference

Stifel 2024 Healthcare Conference

  • Post author:Allogene Therapeutics
  • Post published:November 18, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingStifel 2024 Healthcare Conference

November 18, 2024 8:35 AM EST : Stifel 2024 Healthcare Conference

  • Post author:Allogene Therapeutics Events
  • Post published:November 18, 2024
  • Post category:Uncategorized

Continue ReadingNovember 18, 2024 8:35 AM EST : Stifel 2024 Healthcare Conference

Allogene Therapeutics Third Quarter 2024 Conference Call

  • Post author:Allogene Therapeutics
  • Post published:November 7, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingAllogene Therapeutics Third Quarter 2024 Conference Call

November 7, 2024 5:00 PM EST : Allogene Therapeutics Third Quarter 2024 Conference Call

  • Post author:Allogene Therapeutics Events
  • Post published:November 7, 2024
  • Post category:Uncategorized

Continue ReadingNovember 7, 2024 5:00 PM EST : Allogene Therapeutics Third Quarter 2024 Conference Call

Goldman Sachs Cell Therapy Day Conference

  • Post author:Allogene Therapeutics
  • Post published:October 1, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingGoldman Sachs Cell Therapy Day Conference

October 1, 2024 1:00 PM EDT : Goldman Sachs Cell Therapy Day Conference

  • Post author:Allogene Therapeutics Events
  • Post published:October 1, 2024
  • Post category:Uncategorized

Continue ReadingOctober 1, 2024 1:00 PM EDT : Goldman Sachs Cell Therapy Day Conference
  • Go to the previous page
  • 1
  • 2
  • 3
  • Go to the next page
Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

Phone: 650-457-2700

View Map / Contact Us

LinkedIn
X (Twitter)
  • PIPELINE
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry
Facebook
X (Twitter)
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

Phone: 650-457-2700

View Map / Contact Us

LinkedIn
X (Twitter)
  • PIPELINE
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry

©2026 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE

©2026 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE